Byetta Added to Type 2 Regimens Improves Control

From the Spring Research Guide

| Apr 1, 2006

A recent study compared the effect of adding exenatide (Byetta) or insulin glargine (Lantus) to type 2 patients’ treatment regimens. The type 2s previously had been taking metformin and a sulfonylurea with little success.

According to the researchers, patients taking Byetta at dosages of 10 micrograms twice daily achieved reductions in glucose measures similar to those of patients taking Lantus.

“[Byetta] reduced postprandial glucose excursions more than insulin glargine, while insulin glargine reduced fasting glucose concentrations more than [Byetta],” write the researchers.

Byetta patients also lost an average of 5 pounds, while patients on Lantus gained an average of 4 pounds. Rates of symptomatic hypoglycemia were similar between treatment groups.

The most common adverse event for Byetta users was nausea, which was experienced by 57 percent of the participants. Six percent of Byetta participants discontinued its use due to nausea.

Annals of Internal Medicine, October 18, 2005

Click Here To View Or Post Comments

Categories: Byetta, Insulin, Lantus, Low Blood Sugar, Professional Issues, Type 2 Issues


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Comments


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.